Why Hong Kong scientists think GLP-1 weight-loss drugs can help stroke patients

Chinese University of Hong Kong scientists call GLP-1 ‘superstar pathway in biological, medical and pharmaceutical fields’ Popular weight-loss injections have the potential to help patients recover from severe strokes when used alongside a surgical procedure to remove blood clots in the brain, scientists at the Chinese University of Hong Kong (CUHK) have said. The scientists said on Thursday that administering a GLP-1 injection before and after a thrombectomy, a blood clot removal procedure, could have neuroprotective effects and improve the neurological recovery of ischemic stroke patients by as much as 20 per cent if they missed the window for an intravenous thrombolysis. Dr Ko Ho, director of the Gerald Choa Neuroscience Institute and an associate professor of CU Medicine, said the team made the discovery while pursuing effective interventions targeting ageing-related biological changes. “Our team began prioritising the GLP-1 signalling pathway about seven or eight years ago. GLP-1 is a ‘superstar’ pathway in biological, medical and pharmaceutical fields, primarily due to its success in treating type 2 diabetes and obesity,” he said.

Read the full article at the source →